Physician profile
Eric Lu
NPI 1841498565
$4,662.60
in general payments reported to CMS, 2019-2025
22 companies · $1,574 in 2025
The $1,574 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $163 · 2022: $853 · 2023: $870 · 2024: $1,203 · 2025: $1,574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,635 · Education: $11.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,635.34 |
| Education | $11.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $778.92 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $569.92 | 2022-2025 | Breztri, Farxiga, Airsupra |
| Amgen INC. | $566.17 | 2021-2025 | Repatha, Otezla, Otezla |
| Lilly USA, LLC | $499.25 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $416.58 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $378.65 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $195.14 | 2022-2023 | Xarelto |
| Glaxosmithkline, LLC. | $173.67 | 2023-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Exact Sciences Corporation | $169.36 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $164.79 | 2022-2025 | Jardiance |
| Dexcom, INC. | $163.27 | 2022-2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $133.13 | 2022-2025 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $95.12 | 2022-2025 | Gardasil 9, Vaxneuvance, Gardasil |
| Phathom Pharmaceuticals, INC. | $92.86 | 2024-2025 | Voquezna |
| Abbott Laboratories | $87.05 | 2022-2025 | Id Now Instrument |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $48.99 | 2024-2025 | |
| Cipher Pharmaceuticals US LLC | $32.95 | 2025 | Natroba, Spinosad |
| Kowa Pharmaceuticals America, INC. | $28.27 | 2022-2025 | Zoryve |
| Sanofi Pasteur INC. | $21.38 | 2022 | |
| Optinose US, INC. | $16.80 | 2025 | |
| Medtronic, INC. | $15.87 | 2023 | Inpen Smart Insulin Delivery System |
| Seqirus USA INC | $14.46 | 2025 | Fluad, Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.